Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Aug;48(8):728–732. doi: 10.1136/jcp.48.8.728

Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.

J M Walboomers 1, A M de Roda Husman 1, P J Snijders 1, H V Stel 1, E K Risse 1, T J Helmerhorst 1, F J Voorhorst 1, C J Meijer 1
PMCID: PMC502799  PMID: 7560199

Abstract

AIM--To assess the value of detecting human papillomavirus (HPV) DNA in false negative archival cervical smears in population based screening programmes for cervical cancer. METHODS--Cytomorphologically classified false negative archival Pap smears (n = 27) taken from 18 women up to six years before cervical cancer was diagnosed were blindly mixed with 89 smears from hospital patients with a variety of gynaecological complaints and tested for HPV by the polymerase chain reaction (PCR). Corresponding cervical cancer biopsy specimens were also available for HPV analysis. Neither the examining cytopathologist nor the molecular biologist was aware of the study design. RESULTS--HPV DNA was detected in the smears of 16 patients with cervical cancer missed previously by cytology. HPV 16 and 18 were found predominantly in those smears taken up to six years before the diagnosis of cervical cancer. The smears of the two remaining patients were reclassified as inadequate for cytology or contained no suitable DNA for PCR. In 15 patients the same HPV type could be found in the smears and the cervical cancer biopsy specimens. CONCLUSIONS--The results indicate that high risk HPV types can be detected in archival smears classified as false negative on cytology and that cytological screening errors may be reduced if combined with PCR testing for HPV.

Full text

PDF
729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergeron C., Barrasso R., Beaudenon S., Flamant P., Croissant O., Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol. 1992 Jul;16(7):641–649. doi: 10.1097/00000478-199207000-00002. [DOI] [PubMed] [Google Scholar]
  2. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boyes D. A. The value of a Pap smear program and suggestions for its implementation. Cancer. 1981 Jul 15;48(2 Suppl):613–621. doi: 10.1002/1097-0142(19810715)48:1+<613::aid-cncr2820481328>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  4. Campion M. J., McCance D. J., Cuzick J., Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet. 1986 Aug 2;2(8501):237–240. doi: 10.1016/s0140-6736(86)92067-2. [DOI] [PubMed] [Google Scholar]
  5. Christopherson W. M., Lundin F. E., Jr, Mendez W. M., Parker J. E. Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period. Cancer. 1976 Sep;38(3):1357–1366. doi: 10.1002/1097-0142(197609)38:3<1357::aid-cncr2820380340>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  6. Coppleson L. W., Brown B. Estimation of the screening error rate from the observed detection rates in repeated cercival cytology. Am J Obstet Gynecol. 1974 Aug 1;119(7):953–958. doi: 10.1016/0002-9378(74)90013-1. [DOI] [PubMed] [Google Scholar]
  7. Cramer D. W. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer. 1974 Dec;34(6):2018–2027. doi: 10.1002/1097-0142(197412)34:6<2018::aid-cncr2820340621>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  8. Devesa S. S., Young J. L., Jr, Brinton L. A., Fraumeni J. F., Jr Recent trends in cervix uteri cancer. Cancer. 1989 Nov 15;64(10):2184–2190. doi: 10.1002/1097-0142(19891115)64:10<2184::aid-cncr2820641034>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  9. Kataja V., Syrjänen S., Mäntyjärvi R., Yliskoski M., Saarikoski S., Syrjänen K. Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis. 1992 May-Jun;19(3):154–160. doi: 10.1097/00007435-199205000-00009. [DOI] [PubMed] [Google Scholar]
  10. Kenemans P. HPV genotype as a prognostic factor for progression to cervical carcinoma in young women. Eur J Obstet Gynecol Reprod Biol. 1994 May 31;55(1):24–25. doi: 10.1016/0028-2243(94)90187-2. [DOI] [PubMed] [Google Scholar]
  11. Koss L. G. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989 Feb 3;261(5):737–743. [PubMed] [Google Scholar]
  12. Lorincz A. T., Reid R., Jenson A. B., Greenberg M. D., Lancaster W., Kurman R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992 Mar;79(3):328–337. doi: 10.1097/00006250-199203000-00002. [DOI] [PubMed] [Google Scholar]
  13. Melkert P. W., Hopman E., van den Brule A. J., Risse E. K., van Diest P. J., Bleker O. P., Helmerhorst T., Schipper M. E., Meijer C. J., Walboomers J. M. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer. 1993 Apr 1;53(6):919–923. doi: 10.1002/ijc.2910530609. [DOI] [PubMed] [Google Scholar]
  14. Miller A. B. Evaluation of the impact of screening for cancer of the cervix. IARC Sci Publ. 1986;(76):149–160. [PubMed] [Google Scholar]
  15. Miller A. B., Lindsay J., Hill G. B. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer. 1976 May 15;17(5):602–612. doi: 10.1002/ijc.2910170508. [DOI] [PubMed] [Google Scholar]
  16. Muñoz N., Bosch F. X., de Sanjosé S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992 Nov 11;52(5):743–749. doi: 10.1002/ijc.2910520513. [DOI] [PubMed] [Google Scholar]
  17. Resnick R. M., Cornelissen M. T., Wright D. K., Eichinger G. H., Fox H. S., ter Schegget J., Manos M. M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990 Sep 19;82(18):1477–1484. doi: 10.1093/jnci/82.18.1477. [DOI] [PubMed] [Google Scholar]
  18. Richart R. M., Barron B. A. Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer. 1981 Mar 1;47(5 Suppl):1176–1181. doi: 10.1002/1097-0142(19810301)47:5+<1176::aid-cncr2820471321>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  19. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  20. Snijders P. J., van den Brule A. J., Schrijnemakers H. F., Snow G., Meijer C. J., Walboomers J. M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990 Jan;71(Pt 1):173–181. doi: 10.1099/0022-1317-71-1-173. [DOI] [PubMed] [Google Scholar]
  21. Van Den Brule A. J., Walboomers J. M., Du Maine M., Kenemans P., Meijer C. J. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer. 1991 May 30;48(3):404–408. doi: 10.1002/ijc.2910480317. [DOI] [PubMed] [Google Scholar]
  22. Wied G. L., Bartels P. H., Bibbo M., Keebler C. M. Frequency and reliability of diagnostic cytology of the female genital tract. Acta Cytol. 1981 Sep-Oct;25(5):543–549. [PubMed] [Google Scholar]
  23. de Roda Husman A. M., Walboomers J. M., Meijer C. J., Risse E. K., Schipper M. E., Helmerhorst T. M., Bleker O. P., Delius H., van den Brule A. J., Snijders P. J. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer. 1994 Mar 15;56(6):802–806. doi: 10.1002/ijc.2910560607. [DOI] [PubMed] [Google Scholar]
  24. van Oortmarssen G. J., Habbema J. D., van Ballegooijen M. Predicting mortality from cervical cancer after negative smear test results. BMJ. 1992 Aug 22;305(6851):449–451. doi: 10.1136/bmj.305.6851.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. van den Brule A. J., Meijer C. J., Bakels V., Kenemans P., Walboomers J. M. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol. 1990 Dec;28(12):2739–2743. doi: 10.1128/jcm.28.12.2739-2743.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van der Graaf Y., Vooijs G. P. False negative rate in cervical cytology. J Clin Pathol. 1987 Apr;40(4):438–442. doi: 10.1136/jcp.40.4.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991 Sep;184(1):9–13. doi: 10.1016/0042-6822(91)90816-t. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES